Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Basal Cell × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Neoplasms 29 Fatigue 23 Depression 22 Prostatic Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Lymphoma, Follicular 15 Lymphoma, Large B-Cell, Diffuse 14 Multiple Myeloma 13 Colorectal Neoplasms 13 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Lung Neoplasms 11 Leukemia, Myeloid, Acute 11 Hodgkin Disease 11 Leukemia, Myeloid, Chronic-Phase 10 Blast Crisis 10 Pain 9 Lymphoma, T-Cell, Cutaneous 9 Leukemia, Myeloid, Accelerated Phase 9 Leukemia, Hairy Cell 9 Anxiety Disorders 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8 Carcinoma, Ovarian Epithelial 8 Vomiting 7 Sezary Syndrome 7

Interventions

HhAntag691 11 Imiquimod 7 Aminolevulinic Acid 7 Photochemotherapy 6 1-phenyl-3,3-dimethyltriazene 6 Tomography, Optical Coherence 5 Surgical Procedures, Operative 5 Biopsy 5 Radiotherapy 4 Itraconazole 4 Curettage 4 sonidegib 3 pembrolizumab 3 Standard of Care 3 Niacinamide 3 Mohs Surgery 3 Microscopy, Confocal 3 tazarotene 2 methyl 5-aminolevulinate 2 Watchful Waiting 2 Nivolumab 2 Laser Therapy 2 Gene Expression Profiling 2 Blood Specimen Collection 2 Arsenic Trioxide 2 Acitretin 2 tocilizumab 1 talimogene laherparepvec 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 remetinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610022 2022-08-18

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡